Literature DB >> 12556574

Patterns of change in the treatment of psychiatric symptoms in patients with probable Alzheimer's disease from 1983 to 2000.

Oscar L Lopez1, James T Becker, Robert A Sweet, William Klunk, Daniel I Kaufer, Judith Saxton, Steven T DeKosky.   

Abstract

The authors examined the pattern of use of psychiatric medication as prescribed by community physicians in 1,155 patients with probable Alzheimer's disease (AD) referred to the Alzheimer's Disease Research Center of Pittsburgh between April 1983 and July 2000. The use of antidepressants and of sedatives, hypnotics, and anxiolytics (SHA) increased over time, while the use of antipsychotics decreased. The increased use of antidepressants and decreased use of antipsychotics may reflect the growing evidence that newer antidepressants (e.g., selective serotonin reuptake inhibitors) can be used to treat not only mood-related disorders, but also abnormal behavior (e.g., aggression, agitation) and sleep disorders in AD. Although the use of SHA has a proven deleterious effect on patients with AD, their use has increased over the past two decades.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12556574     DOI: 10.1176/jnp.15.1.67

Source DB:  PubMed          Journal:  J Neuropsychiatry Clin Neurosci        ISSN: 0895-0172            Impact factor:   2.198


  2 in total

1.  Risk of mortality among individual antipsychotics in patients with dementia.

Authors:  Helen C Kales; Hyungjin Myra Kim; Kara Zivin; Marcia Valenstein; Lisa S Seyfried; Claire Chiang; Francesca Cunningham; Lon S Schneider; Frederic C Blow
Journal:  Am J Psychiatry       Date:  2011-10-31       Impact factor: 18.112

2.  Long-term effects of the concomitant use of memantine with cholinesterase inhibition in Alzheimer disease.

Authors:  O L Lopez; J T Becker; A S Wahed; J Saxton; R A Sweet; D A Wolk; W Klunk; S T Dekosky
Journal:  J Neurol Neurosurg Psychiatry       Date:  2009-02-09       Impact factor: 10.154

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.